Climate Change Data

SMS Pharmaceuticals Limited

Climate Impact & Sustainability Data (2021-22, 2022-03 to 2023-03, 2023-24)

Reporting Period: 2021-22

Environmental Metrics

Total Energy Consumption:1.89 Lakhs units/year
Water Consumption:180 KL/day

ESG Focus Areas

  • Environment
  • Social
  • Governance

Environmental Achievements

  • First Indian pharma company to receive Indo-US GCNC Award for adopting green chemistry practice
  • Energy saving of 1.89 Lakhs units/year and water recycled 180 KL/day
  • Investment in state-of-the-art pollution control equipment

Social Achievements

  • Construction of RCC GF+FF school building (8 Nos of class rooms) in Andhra Pradesh
  • CSR Expenditure of 166.20 Lakhs
  • 22600 training hours and 230 training and development initiatives

Governance Achievements

  • Established a Vigil Mechanism and a Whistle blower Policy
  • Annual evaluation of its own performance, Board Committees and individual Directors
  • Familiarization programmes for Independent Directors

Climate Goals & Targets

Short-term Goals:
  • Consolidate existing operations around Ibuprofen, ARV and new product approvals

Environmental Challenges

  • Rise in input cost pressures in Q4 of FY22, resulting in sharp inventory correction at customer end and minimal offtake for ARV products
  • Supply chain bottlenecks and rising input costs
  • Covid-19 pandemic & global inflation
Mitigation Strategies
  • Undertook expansion plans at Visakhapatnam facility
  • Leveraged robust R&D capabilities
  • Enhanced capabilities to expand product pipeline across more therapeutic areas
  • Implemented short-term and long-term measures to combat the impact of Covid-19

Supply Chain Management

Responsible Procurement
  • Sourcing from MSME units

Climate-Related Risks & Opportunities

Awards & Recognition

  • Indo-US GCNC Award
  • Pandit Jawaharlal Nehru Silver Rolling Trophy
  • Indian Pharma Bulk Drug Company of the Year Award
  • India Pharma Bulk Drug Export Company of the Year Award

Reporting Period: 2022-03 to 2023-03

Environmental Metrics

Total Carbon Emissions:61308.87 tCO2e/year (Scope 1 & 2)
Scope 1 Emissions:32757.70 tCO2e/year
Scope 2 Emissions:28551.17 tCO2e/year
Scope 3 Emissions:31.87 tCO2e/year
Total Energy Consumption:447448.46 (A+B+C)
Water Consumption:57071.65 kiloliters/year
Waste Generated:339.98 tons/year

ESG Focus Areas

  • Environmental
  • Social
  • Governance

Environmental Achievements

  • Obtained the Indo-US GCNC award for green chemistry practices
  • Invested in state-of-the-art pollution control equipment
  • Organized tree-planting campaigns

Social Achievements

  • Implemented various measures for employee well-being (health insurance, accident insurance, etc.)
  • Provided training on health and safety measures and skill upgradation
  • Implemented Occupational Health and Safety management system

Governance Achievements

  • ESG reporting assists businesses in identifying and managing risks, improving operations, and making better decisions.

Climate Goals & Targets

Short-term Goals:
  • Reengineering the manufacturing process of various products including Ibuprofen, decreasing of wastage, reducing the production cycle time, increasing batch size by the end of march 2024

Environmental Challenges

  • ESG compliance
  • Regulatory compliance
  • Changing global political and economic conditions
  • Supply chain sustainability
  • Environmental risks
  • Product and quality risks
Mitigation Strategies
  • Advocating and practicing sustainability
  • Strict adherence to regulations
  • Careful business strategy planning
  • Improvement in sourcing of key raw materials
  • Sustaining environmental policies
  • Robust R&D capabilities

Supply Chain Management

Responsible Procurement
  • Preferential procurement policy for MSMEs/small producers

Climate-Related Risks & Opportunities

Awards & Recognition

  • Indo-US GCNC award for green chemistry practices

Reporting Period: 2023-24

Environmental Metrics

Total Carbon Emissions:70,000 Metric tonnes of CO2 equivalent (Scope 1 & 2)
Scope 1 Emissions:37,382.48 Metric tonnes of CO2 equivalent
Scope 2 Emissions:42,378.97 Metric tonnes of CO2 equivalent
Scope 3 Emissions:200.61 Metric tonnes of CO2 equivalent
Total Energy Consumption:547,315.59 Lakh Units
Water Consumption:165,873 KL
Waste Generated:1731.40 Metric tonnes

ESG Focus Areas

  • Environment stewardship
  • Community development
  • Corporate Governance

Environmental Achievements

  • Received the Indo-US GCNC award for implementing green chemistry practices
  • Developed a commercial process to produce Neopentyl glycol from waste generated during Ibuprofen synthesis
  • Operates as a Zero Liquid Discharge (ZLD) unit at Hyderabad

Social Achievements

  • CSR initiatives focused on healthcare, education, and rural development
  • Construction of school buildings
  • Establishing an R.O. water plant in nearby villages

Governance Achievements

  • Robust Board of Directors with diverse backgrounds
  • Well-established corporate governance framework
  • Committees for Audit, Nomination and Remuneration, Stakeholders Relationship, Corporate Social Responsibility, and Risk Management

Climate Goals & Targets

Environmental Challenges

  • Global economic uncertainties
  • Geopolitical risks affecting supply chains
  • Regulatory compliance costs
Mitigation Strategies
  • Backward integration to manage raw material costs
  • Cost optimization efforts
  • Monitoring geopolitical events and regulatory changes

Supply Chain Management

Responsible Procurement
  • Sourcing from domestic market
  • Efforts to reduce dependence on imports

Climate-Related Risks & Opportunities

Sustainable Products & Innovation

  • Neopentyl glycol from waste

Awards & Recognition

  • Indo-US GCNC Award